Accessibility Menu
Arrow-Thin-Down
S&P 500
6,737.49
-1.7%
-113.43
Arrow-Thin-Down
DJI
47,457.22
-1.7%
-797.60
Arrow-Thin-Down
NASDAQ
22,870.36
-2.3%
-536.10
Arrow-Thin-Down
Bitcoin
$97,153.00
-5.6%
-$5,764.33
Arrow-Thin-Down
AAPL
$272.90
-0.2%
-$0.57
Arrow-Thin-Down
AMZN
$237.40
-2.8%
-$6.80
Arrow-Thin-Down
GOOG
$279.12
-2.9%
-$8.31
Arrow-Thin-Down
META
$609.89
+0.1%
+$0.88
Arrow-Thin-Down
MSFT
$502.79
-1.6%
-$8.35
Arrow-Thin-Down
NVDA
$186.79
-3.6%
-$7.01
Arrow-Thin-Down
TSLA
$402.20
-6.6%
-$28.41
Daily Stock GainersDaily Stock LosersMost Active Stocks
Fidelity Select Portfolios - Biotechnology Portfolio Stock Quote

Fidelity Select Portfolios - Biotechnology Portfolio (NASDAQMUTFUND: FBIOX)

$24.58
(0.9%)
+0.21
Price as of November 11, 2025, 7:00 p.m. ET

KEY DATA POINTS

Current Price
$24.58
Daily Change
(0.9%) +$0.21
Day's Range
$24.58 - $24.58
Previous Close
$24.58
Open
$24.37
Beta
0
Volume
-
Average Volume
-
Sector
Financials
Market Cap
0
Market Cap / Employee
-
52wk Range
$24.58 - $24.58
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
$0.00
CAPs Rating
-
Industry
Capital Markets

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Fidelity Select Portfolios - Biotechnology Portfolio Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
FBIOX+16.77%+25.3%+4.61%+1,901%
S&P+12.57%+87.93%+13.44%+1,348%

Fidelity Select Portfolios - Biotechnology Portfolio Company Info

Fidelity Select Portfolios - Biotechnology Portfolio

News & Analysis

Featured Article

Fidelity Biotech Fund: Better than the Index?

Fidelity Select Biotechnology Fund has crushed the broader market, but doesn't fare so well when compared to other biotech mutual funds and ETFs.

Jordan Wathen  |  Jan 15, 2017
No financial data available at this time.

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services